← Back to Search

Task-Based + Virtual Reality for Upper Extremity Weakness

N/A
Waitlist Available
Led By Nancy L Devine, PT, DPT, MS
Research Sponsored by Idaho State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1st week, 4 weeks, 8 weeks, 12 weeks
Awards & highlights

Study Summary

This trial is testing two interventions for people with one arm that does not function well due to a stroke, head injury, or cerebral palsy. The first intervention is a task-based intervention where the person sets up activities of interest to be done using the involved arm and structuring practice and meaningful feedback to assist learning. The second intervention is a virtual reality intervention where the person wears the virtual reality device and practices virtual tasks using the intact arm while seeing the involved arm.

Who is the study for?
This trial is for adults aged 18-89 with one arm that's not fully functional due to a stroke, brain injury, or cerebral palsy. It's been over a year since their neurologic event. They can't join if they have visual field loss, are currently in PT or OT for the affected arm, have cognitive impairments, perceptual deficits, or seizures.Check my eligibility
What is being tested?
The study tests two interventions: task-based activities and virtual reality therapy to improve upper extremity function. Participants will do each intervention for three weeks (3 sessions/week). They'll be tested before and after both treatments and again one month later.See study design
What are the potential side effects?
While not explicitly stated, potential side effects may include discomfort from repetitive tasks or wearing VR equipment and possible frustration or fatigue during exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1st week, 4 weeks, 8 weeks, 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1st week, 4 weeks, 8 weeks, 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Box & Block Test
Change in Fugl-Meyer Assessment (UE portion)
Change in Stroke Impact Scale 3.0
Secondary outcome measures
Change in Active and Passive Range of Motion
Semi-structured interview

Trial Design

2Treatment groups
Experimental Treatment
Group I: Sequence #2Experimental Treatment1 Intervention
Participants will receive nine 30 minute sessions (over 3 weeks) of intervention B followed by nine 30 minute sessions (over 3 weeks) of intervention B.
Group II: Sequence #1Experimental Treatment1 Intervention
Participants will receive nine 30 minute sessions (over 3 weeks) of intervention A followed by nine 30 minute sessions (over 3 weeks) of intervention B.

Find a Location

Who is running the clinical trial?

Idaho State UniversityLead Sponsor
8 Previous Clinical Trials
2,566 Total Patients Enrolled
Nancy L Devine, PT, DPT, MSPrincipal InvestigatorIdaho State University

Media Library

Task or Virtual Reality Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03811275 — N/A
Hemiplegia/Hemiparesis Research Study Groups: Sequence #2, Sequence #1
Hemiplegia/Hemiparesis Clinical Trial 2023: Task or Virtual Reality Intervention Highlights & Side Effects. Trial Name: NCT03811275 — N/A
Task or Virtual Reality Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03811275 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this study recruiting any additional participants?

"This particular study, which was first posted on September 8th 2018, is no longer actively recruiting. However, clinicaltrials.gov lists 238 other trials currently seeking for participants."

Answered by AI

Who has been deemed suitable to participate in this medical research?

"Applicants of this clinical trial should possess hemiparesis and fall within the specified age range (18-89). Approximately 15 people are sought to participate."

Answered by AI

Does this research include participants aged over 30?

"According to the entrance requirements for this medical trial, eligible candidates must be between 18 and 89 years old. There are 147 clinical trials that accept minors while there is a total of 104 studies available for those above 65."

Answered by AI
~2 spots leftby Apr 2025